New psoriasis drug more effective, safer
May 17th, 2008
Many sufferers of plaque psoriasis (the most common type of psoriasis) have used the drug cyclosporin because of its effective, short-term effects on the skin condition. With extended use of cyclosporin many suffer from kidney difficulties making this a complicated option for some.
However, a new drug, ISA247, recently underwent its third phase of its clinical trials and the outcome was positive. Almost 60 percent of those that used a high does of ISA247 had significant improvements in their psoriasis. ISA247 is taken orally as a calcineurin inhibitor designed to treat autoimmune conditions.
This entry was posted on Saturday, May 17th, 2008 at 3:18 pm and is filed under Psoriasis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
